Novavax Inc (NVAX) stock
NVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$7.96−0.10 (-1.24%)
Close on Nov 17, 2026Market cap $1.31BP/E –Yield –
Novavax price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Novavax's price to book ratio was 36.2× on Oct 31, 2025, against 12.8× a year earlier. Over the last 5 years it ranged from 3.5× to 130.6×, with a median of 8.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Oct 31, 2025 | 36.2× | −29.0 |
| 2022 | Jul 29, 2022 | 65.2× | +41.8 |
| 2021 | Dec 31, 2021 | 23.4× | −42.5 |
| 2020 | Dec 31, 2020 | 65.9× | +58.8 |
| 2017 | Jan 31, 2017 | 7.1× | +0.3 |
| 2016 | Dec 30, 2016 | 6.9× | +0.7 |
| 2015 | Dec 31, 2015 | 6.2× | +0.8 |
| 2014 | Dec 31, 2014 | 5.4× | +0.5 |
| 2013 | Dec 31, 2013 | 4.9× | +0.8 |
| 2012 | Dec 31, 2012 | 4.1× | +1.4 |
| 2011 | Dec 30, 2011 | 2.7× | – |
See a number that looks wrong?